Emily Mackler, PharmD, BCOP is the Director of Clinical Quality Initiatives at the Michigan Oncology Quality Consortium (MOQC) and Adjunct Clinical Associate Professor at the University of Michigan College of Pharmacy.

Dr. Mackler received her PharmD from Drake University and completed her residency experience in Pharmacy Practice and Oncology at the University Hospital in Cincinnati, OH, under the mentorship of Jane Pruemer. She joined the University of Michigan Health System in 2002 as a Clinical Oncology Pharmacist. She founded the Oncology Specialty Residency at the University of Michigan in 2003 and was the program director until 2013. She has been involved in multiple oncology quality and safety endeavors including serving as the co-lead and founding developer of the NCCN Chemotherapy Order Templates since its inception in 2006, founding pharmacist in the Cancer Center Symptom Management and Supportive Care Program at the University of Michigan 2009 – 2012, founding director of the University of Michigan Oral Chemotherapy Program in 2012 and thereafter MOQC’s Oral Oncolytic Program in 2013, and founding course director of the Michigan Society of Hematology Oncology (MSHO) Annual Pharmacist’s meeting from 2013 - 2019.

Dr. Mackler’s research and practice interests focus on oncology symptom management, quality of care, oncology-primary care collaboration, medication adherence and patient reported outcomes.

Past HOPA Involvement

• Board of Directors Member-At-Large 2020 – present
• Quality Oversight Committee Chair 2019 – 2020
• Quality Oversight Task Force Chair 2018 – 2019
• National Quality Forum HOPA Liaison 2017 – present
• Oral Chemotherapy Task Force Chair 2017 – 2019
• BCOP Recertification Committee Member 2008 – 2010 lg